FT: Terapii cu celule stem la preț de 18.000 de dolari. Cum arată piața înfloritoare a promisiunilor false de longevitate din SUA

A Financial Times investigation reveals a booming market for unproven stem cell therapies in the U.S., raising concerns among experts about their safety and efficacy. Clinics promote these treatments as cures for various ailments, despite lacking scientific validation and facing regulatory scrutiny. The rise of such practices has been fueled by celebrity endorsements and a growing number of providers, leading to potential public health risks. Experts warn that these therapies can cause harm, as many claims are based on pseudoscience rather than solid research.